Denosumab-Treated Giant Cell Tumor of the Bone Mimicking Low-Grade Central Osteosarcoma.
作者信息
Wu Chang-Che, Hsieh Pin-Pen
机构信息
Department of Pathology and Laboratory Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
出版信息
J Pathol Transl Med. 2018 Mar;52(2):133-135. doi: 10.4132/jptm.2016.12.21. Epub 2018 Feb 12.
Abstract
摘要
相似文献
1
Denosumab-Treated Giant Cell Tumor of the Bone Mimicking Low-Grade Central Osteosarcoma.地诺单抗治疗的骨巨细胞瘤酷似低级别中央型骨肉瘤
J Pathol Transl Med. 2018 Mar;52(2):133-135. doi: 10.4132/jptm.2016.12.21. Epub 2018 Feb 12.
2
Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.地诺单抗治疗的骨巨细胞瘤与骨恶性巨细胞瘤存在形态学重叠。
Am J Surg Pathol. 2016 Jan;40(1):72-80. doi: 10.1097/PAS.0000000000000506.
3
Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.一名坐骨复发性巨细胞瘤患者在接受地诺单抗治疗期间发生了高级别骨肉瘤。
Jpn J Clin Oncol. 2017 Nov 1;47(11):1090-1096. doi: 10.1093/jjco/hyx112.
4
Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.巨细胞丰富型骨肉瘤再探讨——诊断标准与组织病理学模式、Ki67、CDK4和MDM2表达、对双膦酸盐和地诺单抗治疗的反应变化
Virchows Arch. 2016 Jun;468(6):741-55. doi: 10.1007/s00428-016-1926-9. Epub 2016 Mar 22.
5
Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.地诺单抗治疗的骨巨细胞瘤。其组织学谱及潜在诊断陷阱。
Hum Pathol. 2017 May;63:89-97. doi: 10.1016/j.humpath.2017.02.008. Epub 2017 Feb 22.
6
Pseudosarcomatous Spindle Cell Proliferation With Osteoid Matrix Mimicking Osteosarcoma: A Distinct Histologic Phenotype in Giant Cell Tumor of Bone Following Denosumab Therapy.伴有类骨质基质的假肉瘤性梭形细胞增生，酷似骨肉瘤：地诺单抗治疗后骨巨细胞瘤中的一种独特组织学表型
Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):e18-9. doi: 10.1097/PAI.0000000000000165.
7
Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.27例地诺单抗治疗后骨巨细胞瘤的临床病理特征：印度一家三级癌症转诊中心的单机构经验
Pathol Oncol Res. 2017 Jan;23(1):157-164. doi: 10.1007/s12253-016-0123-0. Epub 2016 Oct 8.
8
Two Cases of Sarcoma Arising in Giant Cell Tumor of Bone Treated with Denosumab.两例骨巨细胞瘤继发肉瘤接受地诺单抗治疗的病例
Case Rep Med. 2015;2015:767198. doi: 10.1155/2015/767198. Epub 2015 Dec 22.
9
Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.地诺单抗治疗骨巨细胞瘤的临床及病理结果：14例前瞻性研究
Acta Orthop Traumatol Turc. 2017 Jan;51(1):1-6. doi: 10.1016/j.aott.2016.03.004. Epub 2016 Oct 24.
10
Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report.地诺单抗：一种桡骨远端骨巨细胞瘤手术治疗的潜在替代方案：病例报告
J Hand Surg Am. 2015 Aug;40(8):1620-4. doi: 10.1016/j.jhsa.2015.03.018. Epub 2015 Apr 29.
引用本文的文献
1
Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.地舒单抗治疗骨巨细胞瘤患者的肿瘤有效缩小：系统评价和荟萃分析。
Cancer Control. 2020 Jul-Aug;27(3):1073274820934822. doi: 10.1177/1073274820934822.
2
Radiological findings of denosumab treatment for giant cell tumours of bone.地舒单抗治疗骨巨细胞瘤的放射学表现。
Skeletal Radiol. 2020 Sep;49(9):1345-1358. doi: 10.1007/s00256-020-03449-1. Epub 2020 Apr 26.
3
Integration of denosumab therapy in the management of giant cell tumors of bone.地诺单抗治疗在骨巨细胞瘤管理中的整合应用。
J Orthop. 2020 Mar 28;22:38-47. doi: 10.1016/j.jor.2020.03.020. eCollection 2020 Nov-Dec.
本文引用的文献
1
Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.27例地诺单抗治疗后骨巨细胞瘤的临床病理特征：印度一家三级癌症转诊中心的单机构经验
Pathol Oncol Res. 2017 Jan;23(1):157-164. doi: 10.1007/s12253-016-0123-0. Epub 2016 Oct 8.
2
Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.地诺单抗治疗的骨巨细胞瘤与骨恶性巨细胞瘤存在形态学重叠。
Am J Surg Pathol. 2016 Jan;40(1):72-80. doi: 10.1097/PAS.0000000000000506.
3
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.H3F3A 和 H3F3B 的驱动突变可明确区分软骨母细胞瘤和骨巨细胞瘤。
Nat Genet. 2013 Dec;45(12):1479-82. doi: 10.1038/ng.2814. Epub 2013 Oct 27.
4
Giant cell tumor of bone: a basic science perspective.骨巨细胞瘤：基础科学视角。
Bone. 2013 Jan;52(1):238-46. doi: 10.1016/j.bone.2012.10.002. Epub 2012 Oct 9.
5
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.地舒单抗治疗骨巨细胞瘤患者的开放性、2 期研究。
Lancet Oncol. 2010 Mar;11(3):275-80. doi: 10.1016/S1470-2045(10)70010-3. Epub 2010 Feb 10.
6
The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts.骨巨细胞瘤的组织发生：肿瘤细胞与破骨细胞相互作用的模型
Histol Histopathol. 2001 Jan;16(1):297-307. doi: 10.14670/HH-16.297.
7
Low-grade intraosseous osteosarcoma.低级别骨内骨肉瘤
Cancer. 1990 Mar 15;65(6):1418-28. doi: 10.1002/1097-0142(19900315)65:6<1418::aid-cncr2820650629>3.0.co;2-q.
Zotero 插件